substance p has been researched along with cyclic gmp in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (25.32) | 18.7374 |
1990's | 39 (49.37) | 18.2507 |
2000's | 14 (17.72) | 29.6817 |
2010's | 5 (6.33) | 24.3611 |
2020's | 1 (1.27) | 2.80 |
Authors | Studies |
---|---|
Omenn, GS | 1 |
Costa, E; Guidotti, A; Naik, SR | 1 |
Butcher, FR; Rudich, L | 1 |
Brasitus, TA; Kimberg, DV; Walling, MW | 1 |
Albano, J; Bhoola, KD; Harvey, RF | 2 |
Gardner, JD; Jensen, RT | 2 |
Christian, C; Harrowe, G; Mitsuhashi, M; Ohashi, Y; Payan, DG; Shichijo, S; Sudduth-Klinger, J | 1 |
Evans, HG; Lewis, MJ; Shah, AM | 1 |
Hongo, K; Kassell, NF; Pasqualin, A; Torner, JC; Tsukahara, T; Van Beek, O | 1 |
Okamura, T; Toda, N | 2 |
Azadzoi, KM; Brown, ML; Cohen, RA; Goldstein, I; Kim, N; Saenz de Tejada, I | 1 |
Endoh, H; Fujiwara, N; Fukuda, S; Kumagai, Y; Shimoji, K | 1 |
Allen, SP; Chester, AH; Luu, TN; O'Neil, GS; Schyns, CJ; Tadjkarimi, S; Yacoub, MH | 1 |
Nishikawa, M; Okamura, T; Toda, N; Yoshida, K | 1 |
Lang, D; Smith, JA | 1 |
Krukoff, TL | 1 |
Lachowicz, L; Turski, WA | 1 |
Lewis, MJ; Shah, AM; Smith, JA | 1 |
Allen, SP; Chester, AH; Khagani, A; Luu, TN; Musumeci, F; O'Neil, GS; Ridley, P; Tadjkarimi, S; Yacoub, MH | 1 |
Alley, K; Davidovitch, Z; Nicolay, O; Shanfeld, J | 1 |
Li, XQ; Li, XW; Zhu, CX | 1 |
Kessler, JA | 1 |
Malo, PE; Parris, DJ; Pfeiffer, DF; Torphy, TJ; Wasserman, MA | 1 |
Degryse, A; Ooms, L | 1 |
Bossaller, C; Habib, GB; Henry, PD; Wells, S; Williams, C; Yamamoto, H | 1 |
Mistry, A; Vijayan, E | 1 |
Ariano, MA; Kenny, SL | 1 |
Conlon, TP; Gustavson, C; Sjödin, L; Uddholm, K | 1 |
Cramer, H; Kohler, J; Oepen, G; Schomburg, G; Schröter, E | 1 |
Ariano, MA; Tress, EL | 1 |
Bar-Shavit, Z; Goldman, R | 1 |
Bilan, PT; Fleming, N; Graham, KW | 1 |
Grigg, JJ; Koyano, K; Nakajima, S; Nakajima, Y; Velimirovic, BM | 1 |
Fort, S; Lewis, MJ; Shah, AM | 1 |
Dymshitz, J; Vasko, MR | 2 |
Enokibori, M; Okamura, T; Toda, N | 1 |
Garry, MG; Hargreaves, KM; Richardson, JD | 1 |
Hull, AD; Pearce, WJ; White, CR | 1 |
Amerini, S; Geppetti, P; Granger, HJ; Ledda, F; Maggi, CA; Masini, E; Morbidelli, L; Ziche, M | 1 |
Belova, N; Diaz, MC; Duvilanski, BH; Lasaga, M; McCann, SM; Pisera, D; Rettori, V; Seilicovich, A; Zambruno, C | 1 |
Brain, SD; Kajekar, R; Moore, PK | 1 |
Itoh, T; Kamisaki, Y; Nakamoto, K; Wada, K | 1 |
Forssmann, WG; Haverich, A; Heublein, B; Kuhn, M; Lichtlen, PR; Mügge, A; Nolte, C; Warnecke, J | 1 |
Amerini, S; Granger, HJ; Maggi, CA; Morbidelli, L; Parenti, A; Ziche, M | 1 |
Coleman, HA; Parkington, HC; Tare, M; Tonta, MA | 1 |
Edvinsson, L; Jansen-Olesen, I; You, J; Zhang, W | 1 |
Bredt, DS; Chao, DS; Cornwell, TL; Greengard, P; Lincoln, TM; Nairn, AC; Qian, Y; Santillano, DR | 1 |
Nowicki, PT | 1 |
Bina, S; Jing, M; Ledvina, MA; Muldoon, SM; Panico, FG; Panico, JL | 1 |
Hashimoto, T; Hide, I; Inoue, A; Nakata, Y; Nishio, H | 1 |
Benoit, G; Guiliano, F; Jardin, A; Rampin, O | 1 |
Gobbetti, A; Zerani, M | 1 |
Andrade, A; Fernández-Rodriguez, CM; Prieto, J; Quiroga, J; Rodriguez-Ortigosa, C; Zozaya, JM | 1 |
Fukuta, H; Hozumi, T; Suzuki, H | 1 |
Iida, Y; Katusic, ZS; O'Brien, T; Onoue, H; Smith, L; Tsutsui, M | 1 |
Dissing, S; Looms, DK; Nauntofte, B; Tritsaris, K | 1 |
Itoh, T; Kajikuri, J; Suzuki, Y; Suzumori, K | 1 |
Assreuy, J; Baretta, IP; De Lima, TC | 1 |
Hori, M; Karaki, H; Murata, T; Ozaki, H; Sato, K; Yamawaki, H | 1 |
de Vente, J; Hökfelt, T; Holmberg, K; Steinbusch, HM | 1 |
Frantz, S; Kelly, RA; Paulus, WJ | 1 |
Furuyama, S; Michikawa, H; Sakai, T; Sugiya, H | 1 |
Dohi, T; Hanada, T; Hide, I; Ikoma, K; Inoue, A; Kumagai, K; Morioka, N; Nakata, Y; Shiomi, H; Takeda, K; Tamura, Y | 1 |
Herrmann, J; Lerman, A; Lerman, LO; Napoli, C; Rodriguez-Porcel, M; Sawamura, T | 1 |
Del Turco, D; Deller, T; Feil, R; Geisslinger, G; Hofmann, F; Ruth, P; Sausbier, M; Schmidtko, A; Tegeder, I | 1 |
Bodelsson, M; Thorlacius, K | 1 |
de Vente, J; Markerink-van Ittersum, M; Vles, JS | 1 |
Katsuyama, S; Kohno, K; Komatsu, T; Sakurada, C; Sakurada, S; Sakurada, T; Shiohira, H; Tsuzuki, M | 1 |
Katsuyama, S; Komatsu, T; Sakurada, S; Sakurada, T; Sanai, K | 1 |
Fox, CB; James, LC; Menniti, FS; Schmidt, CJ; Seeger, TF; Strick, CA | 1 |
Bełtowski, J; Jamroz-Wiśniewska, A; Wójcicka, G; Wojtak, A | 1 |
Komori, S; Matsuyama, H; Takewaki, T; Unno, T | 1 |
Cao, XH; Gao, X; Li, F; Li, L; Liu, LJ; Liu, ZG; Xu, YP; Yan, XS; Ye, ZY; Zhang, JW; Zhang, Y | 1 |
Komatsu, T | 1 |
Chen, Y; Gao, W; Gao, Y; Lu, W | 1 |
7 review(s) available for substance p and cyclic gmp
Article | Year |
---|---|
Neurochemistry and behavior in man.
Topics: Affective Symptoms; Behavior; Biogenic Amines; Brain Chemistry; Cyclic AMP; Cyclic GMP; Deficiency Diseases; Humans; Neurochemistry; Neurons; Neurotransmitter Agents; Pain; Peptides; Prostaglandins; Proteins; Receptors, Drug; Schizophrenia; Substance P; Substance-Related Disorders; Synaptic Transmission | 1976 |
Pathogenesis and pharmacology of diarrhea.
Topics: Acetylcholine; Animals; Antidiarrheals; Bacterial Toxins; Biological Transport; Calcium; Catecholamines; Chlorides; Cyclic AMP; Cyclic GMP; Diarrhea; Fluid Therapy; Glucagon; Histamine; Intestinal Absorption; Intestinal Mucosa; Intestinal Secretions; Intestines; Lipid Metabolism; Loperamide; Regional Blood Flow; Serotonin; Sodium; Somatostatin; Substance P; Vasoactive Intestinal Peptide; Water-Electrolyte Balance | 1986 |
Receptor for secretagogues on pancreatic acinar cells.
Topics: Animals; Atropine; Bombesin; Calcium; Cholecystokinin; Cyclic GMP; Guinea Pigs; Pancreas; Receptors, Cell Surface; Receptors, Cholinergic; Secretin; Substance P; Vasoactive Intestinal Peptide | 1980 |
On the mechanism of the augmentation of the phagocytic capability of phagocytic cells by Tuftsin, substance P, neurotensin, and kentsin and the interrelationship between their receptors.
Topics: Animals; Binding, Competitive; Calcium; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Erythrocytes; Humans; Macrophages; Mice; Neurotensin; Neutrophils; Oligopeptides; Phagocytes; Phagocytosis; Receptors, Cell Surface; Receptors, Immunologic; Structure-Activity Relationship; Substance P; Tuftsin; Yeasts | 1983 |
[The peripheral pharmacology of erection].
Topics: Acetylcholine; Arteries; Calcitonin Gene-Related Peptide; Calcium; Collagen; Cyclic AMP; Cyclic GMP; Endothelins; Gap Junctions; Humans; Ion Exchange; Male; Muscle Contraction; Muscle Fibers, Skeletal; Muscle, Smooth; Muscle, Smooth, Vascular; Neuropeptide Y; Nitric Oxide; Norepinephrine; Oxygen Consumption; Parasympathetic Nervous System; Penile Erection; Penis; Regional Blood Flow; Second Messenger Systems; Substance P; Sympathetic Nervous System; Transforming Growth Factor beta | 1997 |
Mechanism of allodynia evoked by intrathecal morphine-3-glucuronide in mice.
Topics: Animals; Astrocytes; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; Glutamic Acid; Injections, Spinal; Mice; Morphine Derivatives; Nitric Oxide; Pain; Spinal Cord; Substance P | 2009 |
[Study of Supplementary Analgesics Capable of Reducing the Dosage of Morphine].
Topics: Analgesics, Opioid; Animals; Central Nervous System Stimulants; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Humans; Injections, Spinal; Mice; Morphine; Morphine Derivatives; Neurotransmitter Agents; Nitric Oxide; Nociception; Signal Transduction; Substance P; Synapses | 2016 |
72 other study(ies) available for substance p and cyclic gmp
Article | Year |
---|---|
Central GABA receptor agonists: comparison of muscimol and baclofen.
Topics: Aminobutyrates; Animals; Anticonvulsants; Baclofen; Cerebellum; Cyclic GMP; Diazepam; gamma-Aminobutyric Acid; Harmaline; Isoniazid; Male; Motor Activity; Muscle Tonus; Mycotoxins; Oxazoles; Phenobarbital; Quaternary Ammonium Compounds; Rats; Receptors, Drug; Strychnine; Substance P | 1976 |
Effect of substance P and eledoisin on K+ efflux, amylase release and cyclic nucleotide levels in slices of rat parotid gland.
Topics: Amylases; Animals; Atropine; Cyclic AMP; Cyclic GMP; Eledoisin; Female; Kinetics; Parotid Gland; Phentolamine; Potassium; Propranolol; Rats; Substance P | 1976 |
Effects of calcitonin and substance P on the transport of Ca, Na and Cl across rat ileum in vitro.
Topics: Animals; Biological Transport, Active; Calcitonin; Calcium; Chlorides; Cyclic AMP; Cyclic GMP; Ileum; In Vitro Techniques; Intestinal Mucosa; Intestine, Small; Male; Rats; Sodium; Substance P; Water-Electrolyte Balance | 1977 |
The effect of substance P on cyclic AMP and cyclic GMP levels in actively secreting pancreatic lobules [proceedings].
Topics: Animals; Cyclic AMP; Cyclic GMP; Guinea Pigs; In Vitro Techniques; Pancreas; Peptide Hydrolases; Secretory Rate; Substance P | 1978 |
The messenger role of cyclic GMP and calcium in the exocrine pancreas [proceedings].
Topics: Acetylcholine; Calcium; Cyclic GMP; In Vitro Techniques; Pancreas; Substance P | 1979 |
Interaction of physalaemin, substance P, and eledoisin with specific membrane receptors on pancreatic acinar cells.
Topics: Amylases; Animals; Binding, Competitive; Biological Transport, Active; Calcium; Cyclic GMP; Eledoisin; Guinea Pigs; Kinetics; Kinins; Male; Pancreas; Physalaemin; Receptors, Drug; Substance P | 1979 |
Multiple intracellular signaling pathways of the neuropeptide substance P receptor.
Topics: Animals; Calcium; Cells, Cultured; Colforsin; Cyclic GMP; Fura-2; Iodine Radioisotopes; Protein Kinase C; Rats; Receptors, Neurokinin-1; Receptors, Neurotransmitter; Signal Transduction; Substance P; Transfection | 1992 |
Cyclic GMP inhibits the inotropic response to alpha 1-adrenoceptors in the papillary muscle of the ferret.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Cyclic GMP; Ferrets; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Myocardial Contraction; Nitroprusside; Papillary Muscles; Phenylephrine; Stimulation, Chemical; Substance P | 1992 |
Cerebrovascular effects of substance P after experimental subarachnoid haemorrhage.
Topics: Animals; Basilar Artery; Cyclic GMP; Dose-Response Relationship, Drug; Ischemic Attack, Transient; Male; Nitric Oxide; Rabbits; Subarachnoid Hemorrhage; Substance P; Vasoconstriction; Vasodilation | 1992 |
[Regulation of vascular tone by nitric oxide (NO) derived from endothelium and nerve].
Topics: Animals; Cyclic GMP; Dogs; Endothelium, Vascular; In Vitro Techniques; Nitric Oxide; Peripheral Nerves; Substance P; Vasoconstriction; Vasodilation | 1992 |
Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone.
Topics: Acetylcholine; Animals; Bradykinin; Cholic Acids; Cyclic GMP; Eicosanoids; Endothelium, Vascular; Guanylate Cyclase; Humans; In Vitro Techniques; Indomethacin; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Neurotransmitter Agents; Nitric Oxide; Nitroprusside; Papaverine; Penis; Prostaglandin-Endoperoxide Synthases; Rabbits; Substance P; Vasoactive Intestinal Peptide | 1992 |
Effects of dorsal root entry zone lesions on CSF and plasma neuropeptides and catecholamines.
Topics: Adult; beta-Endorphin; Blood-Brain Barrier; Catecholamines; Cyclic AMP; Cyclic GMP; Female; Ganglia, Spinal; Humans; Male; Middle Aged; Neuralgia; Neuropeptides; Pain Measurement; Pain, Intractable; Substance P | 1992 |
Comparison of cyclic GMP in human internal mammary artery and saphenous vein: implications for coronary artery bypass graft patency.
Topics: Acetylcholine; Bradykinin; Coronary Artery Bypass; Culture Techniques; Cyclic GMP; Endothelium, Vascular; Graft Occlusion, Vascular; Humans; Mammary Arteries; Nitroglycerin; Saphenous Vein; Substance P; Vascular Patency | 1992 |
AE0047, a new dihydropyridine Ca2+ entry blocker, inhibits the responses to adrenergic nerve stimulation and substance P in dog mesenteric arteries.
Topics: Adrenergic alpha-Agonists; Animals; Calcium Channel Blockers; Cyclic GMP; Dihydropyridines; Dogs; Electric Stimulation; Female; In Vitro Techniques; Male; Mesenteric Arteries; Nicardipine; Substance P; Sympathetic Nervous System; Tritium; Vasodilation | 1992 |
Release of endothelium-derived relaxing factor from pig cultured aortic endothelial cells, as assessed by changes in endothelial cell cyclic GMP content, is inhibited by a phorbol ester.
Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Arginine; Calcimycin; Catalase; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Hemoglobins; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Phorbol 12,13-Dibutyrate; Substance P; Superoxide Dismutase; Swine | 1990 |
Neuropeptide regulation of autonomic outflow at the sympathetic preganglionic neuron. Anatomical and neurochemical specificity.
Topics: Animals; Cats; Corticotropin-Releasing Hormone; Cyclic GMP; Enkephalins; Immunoenzyme Techniques; Neuropeptide Y; Neuropeptides; Neurotensin; Neurotransmitter Agents; Spinal Cord; Substance P; Sympathetic Nervous System; Vasoactive Intestinal Peptide | 1990 |
The possibility of participation of different protein kinases in the regulation of degradation of Glp6[125I]Tyr8SP6-11 with different endopeptidases in subcellular fractions of rat brain.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Animals; Brain; Cell Nucleus; Cerebral Cortex; Colforsin; Cyclic AMP; Cyclic GMP; Endopeptidases; Hippocampus; Neurotransmitter Agents; Peptide Fragments; Protease Inhibitors; Protein Kinases; Pyrrolidonecarboxylic Acid; Rats; Second Messenger Systems; Subcellular Fractions; Substance P; Synaptosomes; Tetradecanoylphorbol Acetate | 1991 |
Factors released from endocardium of the ferret and pig modulate myocardial contraction.
Topics: Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Endocardium; Ferrets; Myocardial Contraction; Nitric Oxide; Nitroprusside; Stimulation, Chemical; Substance P; Swine | 1991 |
Endothelial function of human gastroepiploic artery. Implications for its use as a bypass graft.
Topics: Arginine; Coronary Artery Bypass; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; In Vitro Techniques; Indomethacin; Nitroglycerin; omega-N-Methylarginine; Stomach; Substance P; Vascular Patency; Vasodilation | 1991 |
SP immunoreactivity in the dental pulp and periodontium during tooth movement.
Topics: Animals; Cats; Cuspid; Cyclic AMP; Cyclic GMP; Dental Pulp; Nerve Endings; Periodontal Ligament; Stress, Mechanical; Substance P; Tooth Mobility | 1991 |
[Experimental study on the treatment of hypertension with combined traditional Chinese and Western medicine].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Atrial Natriuretic Factor; Cyclic AMP; Cyclic GMP; Drugs, Chinese Herbal; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Substance P; Thromboxane B2 | 1991 |
Differential regulation of peptide and catecholamine characters in cultured sympathetic neurons.
Topics: Animals; Choline O-Acetyltransferase; Cyclic AMP; Cyclic GMP; Ganglia, Sympathetic; Membrane Potentials; Neurotransmitter Agents; Phenotype; Rats; Somatostatin; Substance P; Tyrosine 3-Monooxygenase | 1985 |
Characterization of substance P-induced contractions of guinea-pig trachea.
Topics: Animals; Calcium; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Substance P; Trachea; Vasoactive Intestinal Peptide; Verapamil | 1986 |
Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta.
Topics: Acetylcholine; Animals; Aorta; Arteriosclerosis; Calcimycin; Coronary Vessels; Cyclic GMP; Endothelium; Histamine; Humans; Nitric Oxide; Nitroglycerin; Rabbits; Receptors, Muscarinic; Substance P; Vasodilation; Vasodilator Agents | 1987 |
Differential responses of hypothalamic cAMP and cGMP to substance P and neurotensin in ovariectomized rats.
Topics: Animals; Cyclic AMP; Cyclic GMP; Female; Hypothalamus; Injections, Intravenous; Injections, Intraventricular; Neurotensin; Ovariectomy; Rats; Rats, Inbred Strains; Substance P | 1987 |
Neurochemical differences in the superior cervical ganglion of the spontaneously hypertensive rat stroke-prone variant.
Topics: Animals; Catecholamines; Cerebrovascular Disorders; Cyclic AMP; Cyclic GMP; Ganglia, Sympathetic; Hypertension; Neuropeptides; Nucleotides, Cyclic; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Somatostatin; Substance P | 1987 |
Endothelium-dependent and -independent responses to vasoactive substances of isolated human coronary arteries.
Topics: Acetylcholine; Adult; Aged; Aged, 80 and over; Aging; Bradykinin; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Female; Histamine; Humans; In Vitro Techniques; Infant; Male; Middle Aged; Serotonin; Substance P; Vasoconstrictor Agents; Vasodilator Agents | 1989 |
Interaction of substance P with dispersed pancreatic acinar cells from the guinea pig. Stimulation of calcium outflux, accumulation of cyclic GMP and amylase release.
Topics: Amylases; Animals; Calcium; Ceruletide; Cyclic GMP; Guinea Pigs; Pancreas; Stimulation, Chemical; Substance P | 1980 |
Huntington's chorea-- measurements of somatostatin, substance P and cyclic nucleotides in the cerebrospinal fluid.
Topics: Adult; Aged; Brain; Cyclic AMP; Cyclic GMP; Female; Humans; Huntington Disease; Male; Middle Aged; Somatostatin; Substance P | 1981 |
Co-localization of cyclic GMP in superior cervical ganglion with peptide neurotransmitters.
Topics: Animals; Autonomic Fibers, Postganglionic; Cyclic GMP; Enkephalin, Methionine; Fluorescent Antibody Technique; Ganglia, Sympathetic; Neurons; Peptides; Rats; Rats, Inbred Strains; Somatostatin; Substance P; Synaptic Transmission | 1983 |
Effect of substance P on exocrine secretion by rat submandibular gland cells.
Topics: Animals; Carboxylic Ester Hydrolases; Cells, Cultured; Cyclic AMP; Cyclic GMP; Isoproterenol; Male; Mucins; Norepinephrine; Rats; Rats, Inbred Strains; Submandibular Gland; Substance P | 1984 |
Two signal transduction mechanisms of substance P-induced depolarization in locus coeruleus neurons.
Topics: Amiloride; Animals; Cells, Cultured; Cyclic AMP; Cyclic GMP; Electrophysiology; Locus Coeruleus; Neurons; Rats; Rats, Inbred Strains; Signal Transduction; Substance P; Tetrodotoxin; Time Factors; Tubocurarine | 1993 |
The role of endocardial endothelium in the modulation of myocardial contraction in the isolated whole heart.
Topics: Animals; Cyclic GMP; Endocardium; Endothelium; Female; Ferrets; Male; Myocardial Contraction; Myocardium; Nitric Oxide; Nitroprusside; Perfusion; Substance P; Ventricular Function, Left | 1993 |
Endothelin-1 enhances capsaicin-induced peptide release and cGMP accumulation in cultures of rat sensory neurons.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cells, Cultured; Cyclic GMP; Endothelins; Ganglia, Spinal; Neurons, Afferent; Rats; Rats, Sprague-Dawley; Substance P | 1994 |
Mechanism underlying substance P-induced relaxation in dog isolated superficial temporal arteries.
Topics: Analysis of Variance; Animals; Arginine; Cyclic AMP; Cyclic GMP; Dogs; Electrophysiology; Endothelium, Vascular; Female; In Vitro Techniques; Indomethacin; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Substance P; Temporal Arteries | 1994 |
Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cyclic GMP; Ferricyanides; In Vitro Techniques; Male; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 1994 |
Endothelium-derived relaxing factor and cyclic GMP-dependent vasorelaxation in human chorionic plate arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Arteries; Bradykinin; Calcimycin; Chorion; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Female; Histamine; Humans; Muscle Contraction; Muscle Relaxation; Nitric Oxide; Pregnancy; Prostaglandin Endoperoxides, Synthetic; Serotonin; Substance P; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1994 |
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cell Division; Cell Movement; Cells, Cultured; Cyclic GMP; DNA; Endothelium, Vascular; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Platelet Aggregation; Rabbits; Substance P | 1994 |
Role of nitric oxide in control of prolactin release by the adenohypophysis.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Atrial Natriuretic Factor; Cyclic GMP; Dibutyryl Cyclic GMP; Dopamine; Dose-Response Relationship, Drug; Guanylate Cyclase; Hemoglobins; In Vitro Techniques; Luteinizing Hormone; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 1995 |
Nitric oxide and cyclic guanosine 3',5'-monophosphate do not alter neuropeptide release from rat sensory neurons grown in culture.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cells, Cultured; Cyclic GMP; Molsidomine; Neurons, Afferent; Neuropeptides; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley; Substance P | 1994 |
Essential role for nitric oxide in neurogenic inflammation in rat cutaneous microcirculation. Evidence for an endothelium-independent mechanism.
Topics: Animals; Arginine; Blood Pressure; Cyclic GMP; Endothelium, Vascular; Indazoles; Inflammation; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Regional Blood Flow; Skin; Substance P | 1995 |
Nitric oxide regulates substance P release from rat spinal cord synaptosomes.
Topics: Amino Acids; Animals; Calcium; Cyclic GMP; Electrophysiology; Free Radical Scavengers; Male; Nitric Oxide; Nitroprusside; Nucleotides, Cyclic; Rats; Rats, Wistar; Spinal Cord; Substance P; Synaptosomes | 1995 |
Impaired coronary dilator responses to substance P and impaired flow-dependent dilator responses in heart transplant patients with graft vasculopathy.
Topics: Adult; Analysis of Variance; Blood Flow Velocity; Blood Platelets; Cardiac Catheterization; Coronary Angiography; Coronary Circulation; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Female; Graft Occlusion, Vascular; Heart Transplantation; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Nitroglycerin; Papaverine; Substance P; Vasodilation | 1993 |
Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells.
Topics: Animals; Cattle; Cell Line; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Nitric Oxide; Substance P; Venules | 1993 |
Stretch revealed three components in the hyperpolarization of guinea-pig coronary artery in response to acetylcholine.
Topics: Acetylcholine; Animals; Arginine; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Female; Guinea Pigs; In Vitro Techniques; Indomethacin; Male; Mechanoreceptors; Membrane Potentials; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prostaglandins; Rabbits; Rats; Sheep; Substance P | 1993 |
Relation between cyclic GMP generation and cerebrovascular reactivity: modulation by NPY and alpha-trinositol.
Topics: Acetylcholine; Animals; Basilar Artery; Brain; Cerebral Arteries; Cerebral Veins; Cyclic GMP; Drug Interactions; Guinea Pigs; In Vitro Techniques; Inositol Phosphates; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Neuropeptide Y; Nitroglycerin; Nitroprusside; Platelet Aggregation Inhibitors; Radioimmunoassay; Substance P; Vasodilator Agents | 1995 |
cGMP-dependent protein kinase in dorsal root ganglion: relationship with nitric oxide synthase and nociceptive neurons.
Topics: Animals; Cyclic GMP; Ganglia, Spinal; Nitric Oxide Synthase; Nociceptors; Protein Kinases; Rats; Spinal Cord; Substance P | 1996 |
The effects of ischemia-reperfusion on endothelial cell function in postnatal intestine.
Topics: Age Factors; Animals; Calcimycin; Cyclic GMP; Endothelium; Hemodynamics; Intestinal Mucosa; Ionophores; Mesenteric Arteries; Nitric Oxide; Reperfusion Injury; Substance P; Swine | 1996 |
Diaspirin cross-linked hemoglobin does not alter isolated human umbilical artery or vein tone.
Topics: Acetylcholine; Animals; Aspirin; Cyclic GMP; Dose-Response Relationship, Drug; Hemoglobins; Humans; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; Serotonin; Substance P; Swine; Umbilical Arteries; Umbilical Veins; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
5-Hydroxytryptamine-facilitated release of substance P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP.
Topics: Animals; Cyclic GMP; In Vitro Techniques; Male; Nitric Oxide; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Neurokinin-1; Serotonin; Spinal Cord; Substance P | 1997 |
Cellular mechanism of substance P in the regulation of corticosteroid secretion by newt adrenal gland.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Aldosterone; Animals; Corticosterone; Cyclic GMP; Dinoprostone; Models, Molecular; Nitric Oxide Synthase; Substance P; Triturus | 1997 |
Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.
Topics: Atrial Natriuretic Factor; Case-Control Studies; Cyclic GMP; Female; Hemodynamics; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Natriuresis; Neurotransmitter Agents; Regression Analysis; Substance P | 1997 |
Comparison of the relaxing actions of acetylcholine and substance P in smooth muscle of the guinea-pig aorta.
Topics: Acetylcholine; Animals; Aorta; Biological Factors; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Nitric Oxide; Nitroarginine; Norepinephrine; Potassium; Substance P; Vasodilation | 1997 |
Adventitia-dependent relaxations of canine basilar arteries transduced with recombinant eNOS gene.
Topics: Angiotensin II; Animals; Basilar Artery; Blood Physiological Phenomena; Cyclic GMP; Dogs; Gene Transfer Techniques; In Vitro Techniques; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Recombinant Proteins; Substance P; Vasodilation | 1999 |
Nitric oxide synthesis causes inositol phosphate production and Ca2+ release in rat parotid acinar cells.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Cyclic GMP; Fluorescein; Indicators and Reagents; Inositol Phosphates; Isoproterenol; Male; Nitric Oxide; Parotid Gland; Rats; Rats, Wistar; Substance P | 2000 |
Mechanisms underlying the reduced endothelium-dependent relaxation in human omental resistance artery in pre-eclampsia.
Topics: Adult; Benzimidazoles; Bradykinin; Calcium; Calcium Channel Agonists; Cyclic GMP; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Omentum; Potassium; Pre-Eclampsia; Pregnancy; Substance P; Thromboxane A2; Vasodilation | 2000 |
Nitric oxide involvement in the anxiogenic-like effect of substance P.
Topics: Animals; Arousal; Cyclic GMP; Fear; Female; Maze Learning; Mice; Motor Activity; Nitric Oxide; Substance P | 2001 |
Hypoxia impairs endothelium-dependent relaxation in organ cultured pulmonary artery.
Topics: Animals; Arginine; Biopterins; Caveolin 1; Caveolins; Cyclic GMP; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypoxia; Ionomycin; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroprusside; Organ Culture Techniques; Pulmonary Artery; Rabbits; RNA, Messenger; Substance P; Superoxide Dismutase; Vasoconstriction; Vasodilation; Vasodilator Agents | 2001 |
Distribution of cGMP in guinea pig autonomic ganglia after stimulation with sodium nitroprusside.
Topics: Animals; Cyclic GMP; Ganglia, Sympathetic; Guinea Pigs; Immunohistochemistry; Male; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; Stimulation, Chemical; Substance P; Tyrosine 3-Monooxygenase | 2001 |
Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Failure; Humans; Isoenzymes; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Substance P; Ventricular Function, Left | 2001 |
Methacholine-induced cGMP production is regulated by nitric oxide generation in rabbit submandibular gland cells.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Calcium; Chelating Agents; Cyclic GMP; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Inhibitors; Isoenzymes; Isoproterenol; Methacholine Chloride; Muscarinic Agonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Phenylephrine; Rabbits; S-Nitroso-N-Acetylpenicillamine; Submandibular Gland; Substance P | 2002 |
Nitric oxide synergistically potentiates interleukin-1 beta-induced increase of cyclooxygenase-2 mRNA levels, resulting in the facilitation of substance P release from primary afferent neurons: involvement of cGMP-independent mechanisms.
Topics: Animals; Blotting, Western; Cells, Cultured; Culture Media; Cyclic GMP; Cyclooxygenase 2; Drug Synergism; Enzyme Induction; Ganglia, Spinal; Interleukin-1; Isoenzymes; Neurons, Afferent; Nitric Oxide; Nitric Oxide Donors; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Substance P; Up-Regulation | 2002 |
Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function.
Topics: Animals; Antioxidants; Ascorbic Acid; Bradykinin; Calcimycin; Coronary Artery Disease; Coronary Vessels; Cyclic GMP; Diet, Atherogenic; Endothelin-1; Endothelium, Vascular; Female; Hemodynamics; Hypercholesterolemia; Hypertension, Renovascular; Lipids; Nitric Oxide; Nitroprusside; Oxidative Stress; Renal Artery Obstruction; Renin; Substance P; Swine; Vasodilator Agents; Vitamin E | 2003 |
Reduced inflammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase I.
Topics: Animals; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Formaldehyde; Hot Temperature; Hyperalgesia; Inflammation; Mice; Mice, Knockout; Neurons; Pain; Reaction Time; Substance P; Thionucleotides | 2004 |
Sevoflurane promotes endothelium-dependent smooth muscle relaxation in isolated human omental arteries and veins.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Inhalation; Arteries; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; In Vitro Techniques; Male; Methyl Ethers; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroglycerin; Omentum; Potassium Chloride; Regional Blood Flow; Sevoflurane; Substance P; Vasodilator Agents; Veins | 2004 |
ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord.
Topics: Animals; Astrocytes; Atrial Natriuretic Factor; Axons; Calcitonin Gene-Related Peptide; Cervical Vertebrae; Cyclic GMP; Down-Regulation; Enzyme Inhibitors; Ependyma; Ganglia, Spinal; Immunohistochemistry; Male; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Neurons, Afferent; Phosphoric Diester Hydrolases; Posterior Horn Cells; Protein Isoforms; Rats; Rats, Inbred Lew; Signal Transduction; Spinal Cord; Substance P; Vesicular Acetylcholine Transport Proteins | 2006 |
Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide.
Topics: Analgesics; Animals; Behavior, Animal; Butadienes; Central Nervous System Stimulants; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Injections, Spinal; Isoindoles; Male; Mice; Mice, Inbred Strains; Morphine Derivatives; Nitric Oxide; Nitriles; Nociceptors; Pain; Peptide Fragments; Piperidines; Pyrrolidonecarboxylic Acid; Receptors, Tachykinin; Specific Pathogen-Free Organisms; Spinal Cord; Stereoisomerism; Substance P | 2009 |
Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A.
Topics: Animals; Corpus Striatum; Cyclic AMP; Cyclic GMP; Enkephalins; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Neurons; Nitric Oxide Synthase Type I; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substance P | 2010 |
Chronic hyperleptinemia induces resistance to acute natriuretic and NO-mimetic effects of leptin.
Topics: Androstadienes; Animals; Aorta; Blood Pressure; Cyclic GMP; Humans; Insulin; Kidney Medulla; Leptin; Male; Natriuresis; Nitric Oxide; Obesity; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Ribonucleosides; Sodium; Sodium-Potassium-Exchanging ATPase; Substance P; Wortmannin | 2010 |
Nitrergic inhibition of tachykininergic neuro-muscular transmission via cyclic GMP in the hamster ileum.
Topics: Animals; Cricetinae; Cyclic GMP; Ileum; Male; Membrane Potentials; Mesocricetus; Myocytes, Smooth Muscle; Neuromuscular Junction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxadiazoles; Quinoxalines; Substance P; Tachykinins | 2011 |
Complex regulation of capsaicin on intracellular second messengers by calcium dependent and independent mechanisms in primary sensory neurons.
Topics: Animals; Calcium; Capsaicin; Cells, Cultured; Cyclic AMP; Cyclic GMP; Male; Neurons; Protein Kinase C; Rats; Rats, Sprague-Dawley; Second Messenger Systems; Signal Transduction; Substance P; TRPV Cation Channels | 2012 |
Influence of acupuncture on the expression of VIP, SP, NKA and NKB, cAMP/cGMP and HE content and treatment of bronchial asthma in rats.
Topics: Acupuncture Therapy; Animals; Asthma; Cyclic AMP; Cyclic GMP; Immunohistochemistry; Inflammation Mediators; Lung; Male; Neurokinin B; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 2020 |